Matisse Capital’s BlackRock ESG Capital Allocation Term Trust ECAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-100,000
Closed -$1.56M 174
2023
Q1
$1.56M Hold
100,000
1.01% 18
2022
Q4
$1.34M Hold
100,000
1.19% 26
2022
Q3
$1.28M Buy
100,000
+9,000
+10% +$130K 1.62% 21
2022
Q2
$1.3M Buy
+91,000
New +$1.35M 1.24% 21

Other funds holding ECAT

Matisse Capital's ECAT Position: Q2 2023 in Review

Matisse Capital sold out of BlackRock ESG Capital Allocation Term Trust (ECAT) in Q2 2023, closing a stake of 100,000 shares — an estimated $1.56M sold.

Matisse Capital first reported a position in ECAT in Q2 2022 and held it in 4 quarters. The position peaked at $1.56M in Q1 2023. 67 funds tracked by Wall St. Rank hold ECAT as of Q2 2023.

  • Matisse Capital reported no remaining BlackRock ESG Capital Allocation Term Trust position as of Q2 2023 after selling out during the quarter.
  • Matisse Capital sold 100,000 BlackRock ESG Capital Allocation Term Trust shares in Q2 2023, an estimated $1.56M.
  • Matisse Capital first reported a position in BlackRock ESG Capital Allocation Term Trust in Q2 2022 and held it in 4 quarters.
  • Matisse Capital's BlackRock ESG Capital Allocation Term Trust position peaked at $1.56M in Q1 2023.
  • 67 funds tracked by Wall St. Rank held BlackRock ESG Capital Allocation Term Trust as of Q2 2023.

Based on Matisse Capital's 13F filing for Q2 2023, filed 2 Aug 2023.